Subject of the day
AFX.DE
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company has a strategic collaboration with Envision Health Technologies Inc. to help advance glaucoma care through gamified virtual reality technology. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
| Line | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | $490.50M | $560.02M | $549.63M | $627.54M |
| Gross profit | $252.10M | $301.73M | $289.70M | $331.70M |
| Operating income | $28.00M | $71.18M | $53.06M | $71.12M |
| Net income | $15.70M | $45.33M | $28.38M | $51.81M |
| Diluted EPS | 0.18 | 0.52 | — | — |
| Free cash flow | -$26.30M | -$5.79M | $97.79M | $67.56M |
$30.44
▲ +0.62 (+2.1%)
| 52w hi | $46.67 |
|---|---|
| 52w lo | $22.90 |
| Vol | 360.99K |
| As of | Aug 13 |
Our score +0.17
| Short | +0.01 |
|---|---|
| Medium | +0.25 |
| Long | +0.31 |
computed 2026-08-13
Carl Zeiss Meditec AG
Healthcare · Medical Instruments & Supplies
| Market cap | $2.66B |
|---|---|
| Enterprise value | $3.19B |
| Trailing P/E | 22.22x |
| Forward P/E | 18.68x |
| EV / EBITDA | 14.66x |
| P / S (ttm) | 1.22x |
| Profit margin | 5.6% |
| Return on equity | — |
| Revenue growth | +2.4% |
| Earnings growth | +97.5% |
| Debt / equity | 27.56 |
| Beta vs SPX | 0.48 |
|---|---|
| Corr SPX | 0.16 |
| Annual vol | 47.1% |
| Annual ret | -20.8% |
| Sharpe | -0.44 |
| Max DD | -63.5% |
Window: 504 trading days (489 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.25 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.12 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $29.30 | $30.56 | $29.30 | $30.44 | 360.99K |
| Aug 12 | $30.84 | $30.90 | $29.64 | $29.82 | 335.83K |
| Aug 11 | $27.72 | $31.28 | $27.70 | $31.08 | 618.68K |
| Aug 10 | $29.62 | $30.22 | $29.10 | $30.00 | 317.06K |
| Aug 7 | $29.00 | $30.20 | $28.98 | $29.90 | 380.89K |